SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Rachel Carson — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientRachel Carson
Date of birth1907-05-27
IdentifiersMRN HR-ML041-SYN-TD; SSN (made up) 000-41-5068
Document date1960-03-18
AuthorMargaret Vance-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Results of the breast imaging and biopsy. [S]

History of Present Illness

Ms. Carson returns nine days after presenting with a firm lump in the upper outer left breast. The diagnostic mammogram and ultrasound a week ago showed a 2.4 cm irregular spiculated mass at 2 o'clock, BI-RADS 5, with normal axillary nodes. The ultrasound-guided core biopsy five days ago shows invasive ductal carcinoma, grade 2, ER 95 percent, PR 80 percent, HER2 1+ (negative), Ki-67 22 percent. Before the result was given she was asked what she wanted to know and how; she said she wanted all of it, plainly, and the report in her hand. She was told directly that the biopsy shows breast cancer, that it appears to be early and confined to the breast, and that the aim of treatment is cure. In her own words back she described an early cancer fed by estrogen, to be removed by surgery, with lymph node testing at the operation. She met Dr. Solís-Abernathy this morning and, after hearing the choice between breast-conserving surgery with radiation and mastectomy, chose breast-conserving surgery. She has no bone pain, cough, headache, or weight loss. Her ulcer pain has gone and she is taking omeprazole. She asked that her diagnosis be shared only with a close friend and her editor, and that she be the one to tell them. [S]

ElementDetail
Interval changeImaging BI-RADS 5; core biopsy invasive ductal carcinoma, ER and PR positive, HER2 negative
DisclosureTold the diagnosis in person in plain words; report copy given; teach-back correct
Her decisionBreast-conserving surgery with sentinel node biopsy, after both options were explained
CoordinationBreast surgical oncology seen this morning
PrivacyDiagnosis to be shared only with the two people she names, by her

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo weight loss, fever, or night sweats
BreastPositiveLeft breast lump with a small bruise from the biopsy; no nipple discharge or skin change
MusculoskeletalNegativeNo bone or back pain; knee stiffness unchanged
GastrointestinalNegativeNo epigastric pain, black stools, or vomiting
RespiratoryNegativeNo cough or breathlessness
PsychiatricPositiveWorried and sleeping less since the biopsy; PHQ-9 6, GAD-7 8

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth once daily before breakfast, to complete eight weeks of ulcer healingOne capsule once daily before breakfastOral route1960-01-19 to 1960-04-03completedS
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for knee pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route1959-06-02activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1960-03-18Body height163cmS
1960-03-18Body weight59kgS
1960-03-18Body mass index (BMI) [Ratio]22.2kg/m2S
1960-03-18Systolic blood pressure130mm[Hg]S
1960-03-18Diastolic blood pressure80mm[Hg]S
1960-03-18Heart rate84/minS
1960-03-18Respiratory rate16/minS
1960-03-18Body temperature36.6CelS
1960-03-18Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1960-03-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
1960-03-18Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]8{score}S

Physical Exam

Vital signs recorded on 1960-03-18; see the Vital Signs section. [S]

SystemFinding
GeneralComposed and attentive; takes notes
BreastsLeft breast: 2.5 cm hard, irregular mass at 2 o'clock, mobile on the chest wall, with a small bruise at the biopsy site; no skin dimpling or nipple change. Right breast normal
Lymph nodesNo axillary, supraclavicular, or infraclavicular nodes
AbdomenSoft; no epigastric tenderness; liver not enlarged

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the left breast, upper outer quadrant at 2 o'clock, 2.4 cm on imaging; core biopsy grade 2, estrogen and progesterone receptor positive, HER2 negative, Ki-67 22 percent; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern counterpart of the documented 1894 breast cancer, which was not disclosed to heractiveconfirmed C50.412S — Synthetic tumor details, stage, and treatment; the breast lumps, the 1960 operation, and the nondisclosure are documented (D), but no tumor details from her lifetime are used.
Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 80 percent)activeconfirmed Z17.0S — Synthetic receptor result; no receptor status from her lifetime is known.
New firm lump in the upper outer quadrant of the left breast, found two weeks ago; clinically suspicious; diagnostic imaging and biopsy bookedresolvedconfirmed N63.21S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the lumps in the left breast in early 1960 are documented (D).
Duodenal ulcer found at endoscopy seven weeks ago, with Helicobacter pylori on biopsy; treated with 14 days of bismuth quadruple therapy and completing eight weeks of omeprazole; test of cure plannedactiveconfirmed K26.9S — Synthetic modern ulcer; it echoes the ulcer among her documented illnesses, which the sources do not date.
Primary osteoarthritis of both knees, mild, with stiffness after long walks on the shoreactiveconfirmed M17.0S — Synthetic condition; it is not linked to the documented word arthritis, which she may have used to keep her cancer private.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ImagingDiagnostic mammography and ultrasound of the breast and axillaAt presentation with a palpable massUp to dateDone a week ago: 2.4 cm spiculated mass, BI-RADS 5; normal axillary nodes
LaboratoryCore biopsy with ER, PR, HER2, and Ki-67At diagnosisUp to dateInvasive ductal carcinoma, grade 2; ER 95 percent, PR 80 percent, HER2 1+ (negative), Ki-67 22 percent
Self-managementDisclosure of the diagnosis and shared decision-makingAt diagnosis and at every resultCompleted todayAsked what she wanted to know; told in person in plain words; report copy given; teach-back correct; surgical choice made by her
ImagingBreast MRI for extent of diseaseOptional; considered for dense breasts or uncertain extentNot indicatedSingle lesion in breasts of scattered density; decided with Dr. Solís-Abernathy
ImagingCT, bone scan, or PET for distant spreadOnly with symptoms or clinical stage IIINot indicatedClinical stage T2 N0 with no symptoms of spread
LaboratoryTumor markers (CEA, CA 15-3, CA 27.29)Not recommended for early breast cancerNot indicatedNot ordered
LaboratoryGermline genetic testingAt diagnosis, for breast cancer at 65 or youngerCompleted todayGenetic counseling and a multigene panel today; result expected before surgery
SurveyDistress, depression, and anxiety screen (PHQ-9 and GAD-7)At diagnosis and at periodic intervalsCompleted todayPHQ-9 6 and GAD-7 8, mild; offered the cancer center's counseling service, which she will consider
ExaminationBaseline arm measurements for later lymphedema checksBefore axillary surgeryDueTo be measured at the pre-operative visit
ReferralBreast surgical oncologyAt diagnosisCompleted todaySeen this morning; recommendations in the consultation note
ReferralMedical and radiation oncologyAfter surgery, with the surgical pathologyDueTo review the pathology and recurrence score after surgery
Medication safetyAvoid nonsteroidal anti-inflammatory drugs after surgeryPerioperative, after a recent duodenal ulcerCompleted todaySurgical team informed; acetaminophen for pain
LaboratoryHelicobacter pylori test of cureAt least four weeks after antibiotics and two weeks off a proton pump inhibitorDueUrea breath test planned after surgery

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); Code of Medical Ethics Opinion 2.1.3: Withholding Information from Patients (2016); Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline. J Clin Oncol 2017;35(31):3618-3632 (2017); Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol 2024 (2024); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026)

Follow-up: Genetic result before surgery. Lumpectomy within three weeks. Primary care review about two weeks after surgery, with the pathology. Next scheduled visit 1960-04-20: review two weeks after lumpectomy and sentinel node biopsy: full disclosure of the pathology and the adjuvant treatment decision. [S]